Stock Sales Stock Sales
Stories About

Stock Sales

A lab technician for the company Co-Diagnostics prepares components for a coronavirus test in March in Salt Lake City. The company has come under scrutiny regarding its tests' accuracy and stock sales by leadership at the company. Rick Bowmer/AP hide caption

toggle caption
Rick Bowmer/AP

Stock Sales By Leaders At Coronavirus Testing Company Raise Legal Concerns

  • Download
  • <iframe src="https://www.npr.org/player/embed/940745870/941610862" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Albert Bourla, chairman and CEO of Pfizer, sold millions of dollars' worth of company stock on Monday as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan. Zach Gibson/Bloomberg via Getty Images hide caption

toggle caption
Zach Gibson/Bloomberg via Getty Images

Pfizer CEO Sold Millions In Stock After Coronavirus Vaccine News, Raising Questions

  • Download
  • <iframe src="https://www.npr.org/player/embed/933957580/933967408" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Moderna, based in Cambridge, Mass., has reached phase three trials for its coronavirus vaccine. At the same time, its executives have sold tens of millions of dollars worth of stock, which has led to intense criticism of the company. Maddie Meyer/Getty Images hide caption

toggle caption
Maddie Meyer/Getty Images

'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns

  • Download
  • <iframe src="https://www.npr.org/player/embed/908305074/910788796" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript